Key regions: France, Brazil, South Korea, India, China
Antiviral drugs are medications used to treat viral infections by inhibiting the development of viruses or destroying them. In Argentina, the Antiviral Drugs market is experiencing steady growth due to several factors.
Customer preferences: Customers in Argentina are increasingly becoming aware of the importance of antiviral drugs in treating viral infections. This has led to an increase in demand for antiviral drugs in the country. Additionally, the aging population in Argentina is more susceptible to viral infections, leading to an increased need for antiviral drugs.
Trends in the market: One of the major trends in the Antiviral Drugs market in Argentina is the increasing use of generic drugs. This is due to the lower cost of generic drugs compared to branded drugs. The government has also been promoting the use of generic drugs in the country, which has further fueled the growth of the generic drug segment in the market.Another trend in the market is the increasing focus on research and development of new antiviral drugs. Pharmaceutical companies are investing heavily in research and development to develop new and more effective antiviral drugs. This is expected to drive the growth of the market in the future.
Local special circumstances: Argentina has a well-developed healthcare system, which has contributed to the growth of the Antiviral Drugs market in the country. The government has also been taking steps to improve access to healthcare for all citizens, which has led to an increase in demand for antiviral drugs.
Underlying macroeconomic factors: The economic stability in Argentina has been a major factor contributing to the growth of the Antiviral Drugs market in the country. The country has a strong pharmaceutical industry, which has been able to meet the increasing demand for antiviral drugs. Additionally, the government has been implementing policies to support the growth of the pharmaceutical industry, which has further fueled the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
